Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

Conditions:   Malignant Rhabdoid Tumor;   Rhabdoid Tumor of the Kidney;   Epithelioid Sarcoma;   Chordoma (Poorly Differentiated or De-differentiated);   Atypical Teratoid/Rhabdoid Tumor;   Other INI1 Negative Malignant Tumors (With PI Approval) Interventions:   Drug: Nivolumab;   Drug: Ipilimumab Sponsor:   Dana-Farber Cancer Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials